The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| LIQUIDIA CORP | COM NEW | 53635D202 | 72,562,472 | 9,243,627 | SH | SOLE | 9,243,627 | 0 | 0 | |||
| ANIKA THERAPEUTICS INC | COM | 035255108 | 18,713,160 | 720,291 | SH | SOLE | 720,291 | 0 | 0 | |||
| EVOLUS INC | COM | 30052C107 | 12,796,189 | 1,760,136 | SH | SOLE | 1,760,136 | 0 | 0 | |||
| ADMA BIOLOGICS INC | COM | 000899104 | 3,127,323 | 847,513 | SH | SOLE | 847,513 | 0 | 0 | |||
| STANDARD BIOTOOLS INC | COM | 34385P108 | 16,343,086 | 8,467,920 | SH | SOLE | 8,467,920 | 0 | 0 | |||
| VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 3,869,973 | 183,064 | SH | SOLE | 183,064 | 0 | 0 | |||
| SOCIETAL CDMO INC | COM | 75629F109 | 1,184,995 | 1,077,268 | SH | SOLE | 1,077,268 | 0 | 0 | |||
| EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 2,699,593 | 310,298 | SH | SOLE | 310,298 | 0 | 0 | |||
| ALIMERA SCIENCES INC | COM NEW | 016259202 | 1,398,029 | 478,777 | SH | SOLE | 478,777 | 0 | 0 | |||
| EXELIXIS INC | COM | 30161Q104 | 17,404,050 | 910,730 | SH | SOLE | 910,730 | 0 | 0 | |||
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 136,871 | 4,833 | SH | SOLE | 4,833 | 0 | 0 | |||
| INTERCEPT PHARMACEUTICALS INC | COM | 45845P108 | 14,306,221 | 1,293,510 | SH | SOLE | 1,293,510 | 0 | 0 | |||
| INTERCEPT PHARMACEUTICALS INC | PUT | 45845P958 | 13,272,000 | 1,200,000 | SH | Put | SOLE | 1,200,000 | 0 | 0 | ||